Nurosene, trading under $MEND/$MEND.C, is looking to change the mental health game with its NURO app. Aimed at improving brain function for a healthier, happier, and longer life.
$MEND CSO Dr. Geraci was recently awarded for his research in placebo response related to mental health by the International Society for CNS Clinical Trials and Methodology. Seeing as $MEND’s application will focus on methods that are mainly user-driven in the form of application interaction, this shows promising prospects for the company’s methodologies and practices.
With multiple indicators converging into strong buy signals, shares of $MEND are starting to battle their way back up. It’s really not very common that the RSI, Stochastic, and CM Bottom indicator converge this strongly so I’m really anticipating some big moves. Given the proper catalyst, a spike in volume could send $MEND through the roof.
If shares of $MEND can make up just half of the ground they’ve lost since previous highs, we’ll be looking at ~100% gains.
$MEND’s presentation at the H.C. Wainwright BioConnect conference is now available for the next few days and is worth checking out. Registration is free and the form is linked below.
$MEND is currently trading at $.98 and is valued at an MCAP of $39.33 million.
https://my.ct.events/register.aspx?meid=22d2962c-a482-43a2-8aad-53f12bd1b3da&rpid=41d6be82-5fdd-4e3a-b857-a774c4e1a118